Prelude Capital Management, LLC Amneal Pharmaceuticals, Inc. Transaction History

Prelude Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$5.24 - $6.34 $56,806 - $68,731	10,841 New	10,841 $65,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $24,621 - $32,786	12,562 New	12,562 $24,000
Q1 2021 May 17, 2021	SELL	$4.74 - $7.38 $1.6 Million - $2.5 Million	-338,426 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.95 - $5.42 $254,593 - $349,340	64,454 Added 23.53%	338,426 $1.55 Million
Q3 2020 Nov 16, 2020	BUY	$3.54 - $5.27 $467,740 - $696,325	132,130 Added 93.15%	273,972 $1.06 Million
Q2 2020 Aug 14, 2020	SELL	$2.87 - $5.46 $215,250 - $409,500	-75,000 Reduced 34.59%	141,842 $675,000
Q1 2020 May 15, 2020	BUY	$2.46 - $5.35 $533,431 - $1.16 Million	216,842 New	216,842 $755,000
Q3 2019 Nov 14, 2019	SELL	$2.29 - $7.1 $2,977 - $9,230	-1,300 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$6.44 - $14.29 $8,372 - $18,577	1,300 New	1,300 $9,000
Q3 2018 Nov 14, 2018	SELL	$16.4 - $24.27 $21,992 - $32,546	-1,341 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $18,706 - $27,088	1,341 New	1,341 $22,000

186

137M

234K

45.9K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.24B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.